Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 2, 2013, Pages

  Halasz, Lia M ^a,b   Weeks, Jane C ^c   Neville, Bridget A ^c   Taback, Nathan ^c   Punglia, Rinaa S ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AVERAGE COST; BRAIN METASTASIS; INITIAL TREATMENT; NON SMALL CELL LUNG CANCER; SOCIO-DEMOGRAPHIC CHARACTERISTICS; SOCIO-ECONOMIC STATUS; STEREOTACTIC RADIOSURGERY; SURGICAL RESECTION;

DISEASES; HEALTH INSURANCE; PATIENT MONITORING; PROGRAM DIAGNOSTICS; RADIOTHERAPY;

BRAIN;

AGED; ARTICLE; BRAIN METASTASIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL; SOCIAL STATUS; STEREOTACTIC RADIOSURGERY; UNITED STATES;

AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PHYSICIAN'S PRACTICE PATTERNS; RADIOSURGERY; REGISTRIES; SEER PROGRAM; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84872172090     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.08.007     Document Type: Article

References (23)

1. P.W. Sperduto, S.T. Chao, and P.K. Sneed Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients Int J Radiat Oncol Biol Phys 77 2010 655 661
2. D.W. Andrews, C.B. Scott, and P.W. Sperduto Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial Lancet 363 2004 1665 1672
3. H. Aoyama, H. Shirato, and M. Tago Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial JAMA 295 2006 2483 2491
4. M. Kocher, R. Soffietti, and U. Abacioglu Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study J Clin Oncol 29 2011 134 141
5. E.L. Chang, J.S. Wefel, and K.R. Hess Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial Lancet Oncol 10 2009 1037 1044
6. J.C. Flickinger, and D. Kondziolka Radiosurgery instead of resection for solitary brain metastasis: the gold standard redefined Int J Radiat Oncol Biol Phys 35 1996 185 186
7. L.S. Lal, S.D. Byfield, and E.L. Chang Cost-effectiveness analysis of a randomized study comparing radiosurgery with radiosurgery and whole brain radiation therapy in patients with 1 to 3 brain metastases Am J Clin Oncol 35 1 2012 45 50
8. D. Larson, and A. Sahgal Adjuvant whole brain radiotherapy: strong emotions decide but rationale studies are needed: in reply to Brown et al. (Int J Radiat Oncol Biol Phys 2008;70:1305-1309) [Letters to the Editor] Int J Radiat Oncol Biol Phys 72 2008 959
9. M. Mehta, W. Noyes, and B. Craig A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases Int J Radiat Oncol Biol Phys 39 1997 445 454
10. P.W. Sperduto, and W.A. Hall Radiosurgery, cost-effectiveness, gold standards, the scientific method, cavalier cowboys, and the cost of hope Int J Radiat Oncol Biol Phys 36 1996 511 513
11. M.J. Rutigliano, L.D. Lunsford, and D. Kondziolka The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors Neurosurgery 37 1995 445 453 discussion 453-445
12. National Cancer Institute. Surveillance Epidemiology and End Results. US National Institutes of Health. Available at: http://seer.cancer.gov/index.html. Accessed August 20, 2012.
13. A.L. Potosky, G.F. Riley, and J.D. Lubitz Potential for cancer related health services research using a linked Medicare-tumor registry database Med Care 31 1993 732 748
14. A.F. Eichler, and E.B. Lamont Utility of administrative claims data for the study of brain metastases: a validation study J Neurooncol 95 2009 427 431
15. N. Krieger Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology Am J Public Health 82 1992 703 710
16. R.A. Deyo, D.C. Cherkin, and M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 1992 613 619
17. M.E. Charlson, P. Pompei, and K.L. Ales A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
18. C.N. Klabunde, A.L. Potosky, and J.M. Legler Development of a comorbidity index using physician claims data J Clin Epidemiol 53 2000 1258 1267
19. National Comprehensive Cancer Network. Central Nervous System. Practice Guidelines in Oncology. Available at: http://www.nccn.org/professionals/ physician-gls/pdf/cns.pdf. Accessed on August 28, 2012.
20. B.A. Guadagnolo, C.C. Liu, and J.N. Cormier Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005: socioeconomic disparity and geographic variation in a large population-based cohort Cancer 116 2010 3505 3512
21. D.J. Sher, B.A. Neville, and A.B. Chen Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis Int J Radiat Oncol Biol Phys 81 2011 e197 e206
22. B.D. Smith, I.W. Pan, and Y.C. Shih Adoption of intensity-modulated radiation therapy for breast cancer in the United States J Natl Cancer Inst 103 2011 798 809
23. J.P. Knisely, M. Yamamoto, and C.P. Gross Radiosurgery alone for 5 or more brain metastases: expert opinion survey J Neurosurg 113 suppl 2010 84 89